Chronic News and Research

RSS

Weight Watchers more effective alternative to primary care for obese adults

A new, one-year global study published today in The Lancet indicates that overweight and obese adults referred to Weight Watchers, a community based provider of weight-loss services, lost more than twice as much weight when compared with those who received standard care.

9 Sep 2011

World Cancer Research Fund urges action to stop preventable cancers

According to the WCRF this Wednesday healthier lifestyles and better diets could prevent up to 2.8 million cases of cancer each year. The WCRF called upon governments to “avoid a public health disaster”.

8 Sep 2011

Moderate alcohol intake linked to longer life in women

According to a study published in the journal PLoS Medicine, women may benefit from alcohol consumption. The study showed that middle-age women who indulge in one drink a day or less on a regular basis may have a better chance of being healthier when they’re older.

8 Sep 2011

Angioslide introduces new 5x300mm PROTEUS device for treating Superficial Femoral Artery

Angioslide Ltd. announces the first procedures with its new 5x300mm PROTEUS device for treating the Superficial Femoral Artery. PROTEUS technology combines a Percutaneous Transluminal Angioplasty balloon and embolic capture of particles in one device. The new 5x300 mm size joins Angioslide's current dedicated product line solutions for the lower limbs.

8 Sep 2011

Legal, ethical and cultural barriers to child organ donations

Clinicians from a leading UK children's hospital have called for European countries to change the way they tackle the shortage of organ donations from children, after a review, published in the September issue of Acta Paediatrica, found a large number of legal, ethical and cultural barriers.

8 Sep 2011

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.

From Santen Pharmaceutical Co., Ltd. 8 Sep 2011

Pulitzer photojournalist with lymphoma films his experiences

Diagnosed at age 48 with a potentially deadly form of lymphoma, Pulitzer Prize-winning photojournalist John Kaplan turned the lens on himself and chronicled his experience in a moving visual journal. Kaplan's new film, Not As I Pictured, is now showing on PBS stations nationwide.

8 Sep 2011

Streamlining medical coverage could save costs associated with pediatric obesity

Pediatric obesity ends up costing $3 billion annually in the U.S., but a significant amount of that could be saved by streamlining medical coverage to address health issues affecting young obese patients now rather than waiting to treat conditions they develop as they get older, according UCLA researchers and colleagues.

8 Sep 2011

Calif. woman presses for breast cancer law

For seven straight years since turning 40, Amy Colton religiously scheduled a mammogram. Every year, the test showed nothing. Two years ago, however, the registered nurse was shocked to discover she was in the latter stages of breast cancer. ... Now she's even more shocked that California's powerful medical lobby is trying to block legislation that would require physicians to tell women if they have the condition, known as "extremely dense breast tissue."

8 Sep 2011

Adding azithromycin to usual daily treatment for COPD reduces acute exacerbations by 27%

Richard Casaburi, Ph.D., M.D., principal investigator at Los Angeles Biomedical Research Institute (LA BioMed), is co-author of a recent study that should help improve the condition for the millions of individuals who suffer from chronic obstructive pulmonary disease, better known as COPD.

8 Sep 2011

First-ever comprehensive study of species origins of nature-derived drugs

In a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting the conventional view that as every nature species produces biologically active molecules, one can find drugs from almost any major block of species groups if one looks for them hard enough.

8 Sep 2011

Beta-glucans can help wounds to heal quickly

Can wounds be helped to heal faster? Yes, says a Norwegian company whose product's active ingredient, beta-glucans, comes from common baker's yeast.

8 Sep 2011

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Teva Pharmaceutical Industries Ltd. and Alcobra Ltd. announced today top-line results from a six week, randomized, placebo-controlled, Phase II multi-center study designed to assess the safety and efficacy of MG01CI in adults with attention deficit hyperactivity disorder (ADHD).

7 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.

7 Sep 2011

New bone marrow-derived stem cell therapy can benefit patients with degenerative disc disease

Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs -- the cushions between the bones in the neck -- to relieve chronic, debilitating pain.

7 Sep 2011

Biomaterials may heal chronic diabetic wounds

Biomaterials may prove key to healing chronic wounds in Diabetic patients, delegates will hear today at the 24th European Conference on Biomaterials. Over 950 delegates are at the event in Dublin, which is jointly hosted by NUI Galway's Network of Excellence for Functional Biomaterials and the University of Ulster, Jordanstown.

7 Sep 2011

Chronic News and Research

Weight Watchers more effective alternative to primary care for obese adults

World Cancer Research Fund urges action to stop preventable cancers

Moderate alcohol intake linked to longer life in women

Angioslide introduces new 5x300mm PROTEUS device for treating Superficial Femoral Artery

Legal, ethical and cultural barriers to child organ donations

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Pulitzer photojournalist with lymphoma films his experiences

Streamlining medical coverage could save costs associated with pediatric obesity

Calif. woman presses for breast cancer law

Adding azithromycin to usual daily treatment for COPD reduces acute exacerbations by 27%

First-ever comprehensive study of species origins of nature-derived drugs

Beta-glucans can help wounds to heal quickly

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

New bone marrow-derived stem cell therapy can benefit patients with degenerative disc disease

Biomaterials may heal chronic diabetic wounds

Consuming walnuts slows development and growth of breast cancer tumors

Lung Flute provides relief to Buffalo-area patients with COPD

St. Jude Medical's Genesis neurostimulation device receives European CE Mark approval

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News